Overview
The main aim of this study is to document the level of knowledge and assess attitudes and behaviors of both participants and physicians regarding the risks and safe use of GATTEX. The survey will be done via internet, telephone, or paper and patients will be able to choose the method that is preferred. No study medicines will be provided to patients in this study.
Eligibility
Participant inclusion criteria:
Participants who are 18 years of age or older and who have taken GATTEX in the 60 days
prior to survey implementation are eligible to participate in the survey. A caregiver may
participate in this survey on behalf of a patient who is eligible but unable to complete
the survey. Note: Participants who have previously participated in a GATTEX Patient
Knowledge, Attitudes and Behavior (KAB) Survey, are eligible.
Prescriber inclusion criteria:
HCPs (adult and pediatric) in the United States who can provide a 10-digit National
Provider Identifier (NPI) number and who have prescribed GATTEX at least once regardless of
their completion of the voluntary GATTEX REMS training (Prescriber Education Slide Deck)
are eligible for participation in the survey. Note: HCPs who have previously participated
in a GATTEX HCP KAB Survey, are eligible.
Participant and Prescriber exclusion criteria:
- Respondents who do not agree to participate in the survey.
- Respondents who are currently working for and/or whose immediate family members who
are currently working for Takeda Pharmaceutical Inc., NPS Pharmaceuticals, Inc.,
Shire, UBC, or the Food and Drug Administration (FDA) are not eligible to participate
in the survey.
- Respondents who reported having a conflict of interest.
Further details associated with respondents who do not meet the exclusion criteria
established above, will be provided in the assessment report.